We are live on ! Find out more
DIC

Deer IX & Co Portfolio holdings

AUM $971M
1-Year Est. Return 24.77%
This Fund
S&P 500
This Quarter Est. Return
+40.33%
1 Year Est. Return
-24.77%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
Cap. Flow
+$207M
Cap. Flow %
103.34%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
NCNO icon
nCino
NCNO
+$121M
2
KYMR icon
Kymera Therapeutics
KYMR
+$85.6M
3
DKNG icon
DraftKings
DKNG
+$260K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 50.91%
2 Healthcare 48.97%
3 Consumer Discretionary 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCNO icon
1
nCino
NCNO
$2.43B
$102M 50.91%
+1,562,500
New +$121M
KYMR icon
2
Kymera Therapeutics
KYMR
$9.82B
$97.9M 48.97%
+1,755,356
New +$85.6M
DKNG icon
3
DraftKings
DKNG
$12.5B
$254K 0.13%
+5,463
New +$260K

Similar funds

Deer IX & Co's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Deer IX & Co, which disclosed 3 positions worth $200M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is nCino: 1,562,500 shares worth $102M.

By sector, the portfolio is most concentrated in Technology at 51% of assets, followed by Healthcare and Consumer Discretionary.

  • Deer IX & Co's largest Q4 2020 buy was nCino: 1,562,500 shares worth $102M.
  • Deer IX & Co's ten largest holdings make up 100% of its $200M portfolio in Q4 2020.
  • Deer IX & Co disclosed 3 positions in Q4 2020, its first 13F filing on record.

Based on Deer IX & Co's 13F filing for Q4 2020, filed 16 Feb 2021.